Pharming Group

+$0.26 (+2.75%) As of 7:25 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharming Group and other ETFs, options, and stocks.

About PHAR

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.

CEO
Sijmen de Vries
Employees
—
Headquarters
Leiden, Zuid-Holland
Founded
1988

PHAR Key Statistics

Market Cap
631.72M
Price-Earnings Ratio
35.55
Dividend Yield
—
Average Volume
1.69K
High Today
$9.70
Low Today
$9.70
Open Price
$9.70
Volume
846.00
52 Week High
$21.99
52 Week Low
$9.02

PHAR Earnings

$0.00
$0.01
$0.01
$0.02
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 25, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure